THE EPINEX G1A TEST

REIMAGINING DIABETES CARE

A monthly test for the control of glycation, the underlying cause of the complications of diabetes.

An easily available monthly glycated albumin test could have a broad and beneficial impact across the spectrum of diabetes care, from screening and diagnosis to treatment. A simple, convenient and inexpensive rapid test, available at the point-of-care and as a hand held device for home use, could be the means to translate the promise of glycated albumin technology into improving health outcomes and making real progress against the tide of the diabetes epidemic.

POINT OF CARE MODEL

  • Accurate measurement and graphical analysis of Glycated Albumin

  • Operationally similar to professional diagnostics systems

  • Wireless integration into existing patient data systems

  • Maintains database of patient test results

OVER-THE-COUNTER MODEL

  • Miniaturized, palm-sized

  • Rapid measurement of Glycated Albumin

  • Feels and operates similarly to existing glucose meters

  • Stores patient test results